PEOPLE - Bespak makes appointment:
This article was originally published in Clinica
Executive Summary
Bespak (Milton Keynes, UK), specialist in drug delivery devices, has appointed Scott Kellogg as its new commercial manager, in a bid to enhance their US commercial team. Mr Kellogg will be based in Palm Harbour, Florida, where he will provide a link with Nektar Therapeutics, designers of the PDS device used to deliver the inhaled insulin therapy, Exubera. He will also be in charge of generating new business opportunities for the manufacturing services division. Mr Kellogg was previously the quality manager and lead program Manager for injection moulding and contract-manufacturing firm FCM.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.